Basic science behind the catastrophic epilepsies

Epilepsia

Volumn 45, Issue SUPPL. 5, 2004, Pages 5-11

  Rho, Jong M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Infantile spasms; Intractable epilepsy; Lennox Gastaut syndrome; Mechanism; Pathophysiology; Progressive myoclonus epilepsies

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; KYNURENINE; N METHYL DEXTRO ASPARTIC ACID; SEROTONIN;

BENIGN CHILDHOOD EPILEPSY; BRAIN DISEASE; CATASTROPHIC EPILEPSY; CHILD; CLINICAL FEATURE; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MYOCLONUS EPILEPSY; NERVE DEGENERATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW;

EID: 4043089075     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.05001.x     Document Type: Review

References (67)

1. Rho JM, Storey TW. Molecular ontogeny of major neurotransmitter receptors in the mammalian central nervous system: adrenergic, dopamine, serotonin, acetylcholine, and glycine receptors. J Child Neurol 2001;16:271-80.
2. B receptors in the mammalian central nervous system. J Child Neurol 2003;18:39-48.
3. Simeone TA, Sanchez RM, Rho JM. Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system. J Child Neurol 2004;19:343-60.
4. Blume WT. Pathogenesis of Lennox-Gastaut syndrome: considerations and hypotheses. Epileptic Disord 2001;3:183-96.
5. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990;61:931-7.
6. Vesa J, Hellsten E, Verkruyse LA, et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995;376:584-7.
7. Pennacchio LA, Lehesjoki AE, Stone NE, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:1731-4.
8. Minassian BA, Lee JR, Herbrick JA, et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 1998;20:171-4.
9. Noebels JL. The biology of epilepsy genes. Annu Rev Neurosci 2003;26:599-625.
10. Dulac O, Chugani H, Dalia Bernadina B, eds. Infantile spasms and West syndrome. London: WB Saunders, 1994.
11. Delgado-Escueta AV, Wilson WA, Olsen RW, Porter RJ, eds. Jasper's basic mechanisms of the epilepsies. Philadelphia, PA: Lippincott Williams & Wilkins, 1999. Advances in Neurology; Vol. 39. 3rd ed.
12. Delgado-Escueta AV, Wilson WA, Olsen RW, Porter RJ, eds. Jasper's basic mechanisms of the epilepsies. Philadelphia, PA: Lippincott Williams & Wilkins, 1999. Advances in Neurology; Vol. 39. 3rd ed.
13. Schwartzkroin PA, Rho JM, eds. Epilepsy, infantile spasms, and developmental encephalopathy. New York, NY: Academic Press, 2002. International Review of Neurobiology, Volume 49.
14. Schwartzkroin PA, Rho JM, eds. Epilepsy, infantile spasms, and developmental encephalopathy. New York, NY: Academic Press, 2002. International Review of Neurobiology, Volume 49.
15. Sutula T, Pitkänen A, eds. Do seizures damage the brain. Progress in Brain Research, Vol. 135, Amsterdam: Elsevier, 2002.
16. Pranzatelli MR. On the molecular mechanism of adrenocorticotrophic hormone in the CNS: neurotransmitters and receptors. Exp Neurol 1994;125:142-61.
17. Hol EM, Gispen WH, Bar PR. ACTH-related peptides: receptors and signal transduction systems involved in their neurotrophic and neuroprotective actions. Peptides 1995;16:979-93.
18. Gallo-Payet N, Payet MD. Mechanism of action of ACTH: beyond cAMP. Microsc Res Tech 2003;61:275-87.
19. Jung MJ, Lippert B, Metcalf BW, Bohlen P, Schechter PJ. gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 1977;29:797-802.
20. Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996;47:1567-71.
21. Errante LD, Williamson A, Spencer DD, Petroff OA. Gabapentin and vigabatrin increase GABA in the human neocortical slice. Epilepsy Res 2002;49:203-10.
22. Baram TZ. Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis. Ann Neurol 1993;33:231-6.
23. Brunson KL, Eghbal-Ahmadi M, Bender R, Chen Y, Baram TZ. Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci (USA) 2001a;98:8856-61.
24. Brunson KL, Khan N, Eghbal-Ahmadi M, Baram TZ. Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann Neurol 2001b;49:304-12.
25. Brunson KL, Avishai-Eliner S, Baram TZ. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 2002;49:185-97.
26. Avishai-Eliner S, Brunson KL, Sandman CA, Baram TZ. Stressed-out, or in (utero)? Trends Neurosci 2002;25:518-24.
27. Chiron C, Dulac O, Beaumont D, Palacios L, Pajot N, Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991;(suppl 2):S52-9.
28. Elterman RD, Shields WD, Mansfield KA, Nakagawa J, and the US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001;57:1416-21.
29. Lux AL, Edwards SW, Osborne JP, et al. Randomized trial of vigabatrin in patients with infantile spasms. [Letter] Neurology 2002;59:648.
30. Baram TZ, Mitchell WG, Tournay A, Snead III OC, Hanson RA, Horton EG. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97:375-9.
31. Baram TZ, Hirsch E, Snead III OC, Schultz L. Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol 1992a;31:488-94.
32. Baram TZ, Hatalski CB. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998;21:471-6.
33. Nalin A, Facchinetti F, Galli V, Petraglia F, Storchi R, Genazzani AR. Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. Epilepsia 1985;26:446-9.
34. Baram TZ, Mitchell WG, Snead III OC, Horton EJ, Saito M. Brain adrenal axis hormones are altered in the CSF of infants with massive infantile spasms. Neurology 1992b;42:1171-5.
35. Avishai-Eliner S, Yi SJ, Baram TZ. Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res 1996;91:159-63.
36. Pentella K, Bachman DS, Sandman CA. Trial of an ACTH 4-9 analogue in chlidren with intractable seizures. Neuropediatrics 1982;13:59-62.
37. Willig RP, Lagenstein I. Use of ACTH fragments in children with infantile spasms. Neuropediatrics 1982;13:55-8.
38. Tran V, Hatalski CG, Yan XX, Baram TZ. Effects of blocking GABA degradation on corticotropin-releasing hormone gene expression in selected brain regions. Epilepsia 1999;40:1190-7.
39. McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 1990;15:41-70.
40. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 1999;51:7-61.
41. Tremblay E, Roisin MP, Represa A, Charriaut-Marlangue C, Ben-Ari Y. Transient increased density of NMDA binding sites in the developing rat hippocampus. Brain Res 1988;461:393-6.
42. Represa A, Tremblay E, Ben-Ari Y. Transient increase of NMDA-binding sites in human hippocampus during development. Neurosci Lett 1989;99:61-6.
43. Hardingham GE, Bading H. The yin and yang of NMDA receptor signaling. Trends Neurosci 2003;26:81-9.
44. A, NMDA and AMPA receptors: a developmentally regulated 'menage à trois'. Trends Neurosci 1997;20:523-9.
45. Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 1997;20:464-70.
46. Mares P, Velisek L. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Brain Res Dev Brain Res 1992;65:185-9.
47. Kabova R, Liptakova S, Slamberova R, Pometlova M, Velisek L. Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 1999;40:1357-69.
48. Kohl BK, Dannhardt G. The NMDA receptor complex: a promising target for novel antiepileptic strategies. Curr Med Chem 2001;8:1275-89.
49. Ritter FJ, Leppik IE, Dreifuss FE, and the Felbamate Study Group. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). The felbamate study group in Lennox-Gastaut syndrome. N Engl J Med 1993;328:29-33.
50. A receptors. Ann Neurol 1994;35:229-34.
51. Harty TP, Rogawski MA. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit. Epilepsy Res 2000;39:47-55.
52. Pranzatelli MR. Infantile spasms versus myoclonus: is them a connection? Int Rev Neurobiol 2002;49:285-314.
53. Pranzatelli MR. Antimyoclonic effect of MK-801: a possible role for NMDA receptors in developmental myoclonus of the neonatal rat. Clin Neuropharmacol 1990;13:329-38.
54. Silverstein F, Johnston MV. Cerebrospinal fluid monoamine metabolites in patients with infantile spasms. Neurology 1984;34:102-5.
55. Langlais PJ, Wardlow ML, Yamamoto H. Changes in CSF neurotransmitters in infantile spasms. Pediatr Neurol 1991;7:440-5.
56. Yamamoto H. Studies on CSF tryptophan metabolism in infantile spasms. Pediatr Neurol 1991;17:411-4.
57. Azmitia EC, Gannon PJ, Kheck NM, Whitaker-Azmitia PM. Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacol 1996;14:35-46.
58. Riad M, Emerit MB, Hamon M. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture. Brain Res Dev Brain Res 1994;82:245-58.
59. Chugani HT, Shewmon DA, Sankar R, Chen BC, Phelps ME. Infantile spasms: II. lenticular nuclei and brainstem activation on positron emission tomography. Ann Neurol 1992;31:212-9.
60. Chugani HT, Shields WD, Shewmon DA, Olson DM, Phelps ME, Peacock WJ. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990;27:406-13.
61. Chugani HT, Rintahaka PJ, Shewmon DA. Ictal patterns of cerebral glucose utilization in children with epilepsy. Epilepsia 1994;35:813-22.
62. Juhász C, Chugani HT, Muzik O, Chugani DC. Hypotheses from functional neuroimaging studies. Int Rev Neurobiol 2002;49:37-55.
63. 11C]methyl-L- tryptophan positron emission tomography. Ann Neurol 1998;44:858-66.
64. Yamamoto H, Shindo I, Egawa B, Horiguchi K. Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms. Pediatr Neurol 1994;10:9-12.
65. Stafstrom CE, Holmes GL. Infantile spasms: criteria for an animal model. Int Rev Neurobiol 2002;49:391-411.
66. Kanehisa M. A database for post-genome analysis. Trends Genet 1997;13:375-6.
67. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30.